Please login to the form below

Not currently logged in
Email:
Password:

Generic Pharmaceutical Association

This page shows the latest Generic Pharmaceutical Association news and features for those working in and with pharma, biotech and healthcare.

Novartis weighs in on biosimilar naming debate

Novartis weighs in on biosimilar naming debate

The views of the ASBM have been challenged by the likes of the Generic Pharmaceutical Association (GPhA) who want to keep the current system of biosimilar naming, claiming there is no ... Now Novartis, which has a 50 per cent share of all biosimilars

Latest news

  • Generics industry pressures FDA over biosimilar naming standards Generics industry pressures FDA over biosimilar naming standards

    Trade body the Generic Pharmaceutical Association (GPhA) has filed a Citizen Petition with the Food and Drug Administration (FDA) which claims that there is no clinically meaningful difference between a branded ... For standard generic medicines –

  • US generics group's drug shortage plea

    The US Generic Pharmaceutical Association (GPhA) has blamed intensified regulation for drug shortages in the US and called for greater collaboration between stakeholders to solve the crisis. ... The record number of drug shortages currently ongoing in

  • US generics under scrutiny

    The Generic Pharmaceutical Association (GPhA) puts legislative pressure for carve-outs down to brand manufacturer lobbying. ... Therapeutic equivalence. The FDA essentially treats therapeutic equivalence as a composite of pharmaceutical equivalence and

  • FDA announces generics plan

    The goal is one that the generic drug industry supports, but nonetheless, the proposal has been met with scepticism from the Generic Pharmaceutical Association (GPhA), the trade group for generic drug ... A similar position was taken by The Coalition for

  • Lobbying halts progress of US generic drug laws

    Legislation aimed at speeding the availability of cheaper generic drugs is stalled by intensive lobbying by the pharmaceutical industry. ... The Generic Pharmaceutical Association (GPA) reported lobbying expenses of around USD 420, 000 for the first six

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics